Search This Blog

Thursday, June 1, 2023

Rockwell Med financials, outlook

 

  • Achieved fourth consecutive quarter of revenue growth with new high of $19.7 million, representing a 22.4% increase over the same period in 2022

  • Achieved $2.6 million in gross profit, representing a 425% increase over the same period in 2022

  • Continued to reduce expenses and improve earnings per share with focus on driving enhanced business performance

  • Entered into several new long-term supply, product purchase, and distribution agreements

  • Reiterates 2023 guidance of revenue between $78.0 million and $82.0 million and gross profit between $7.0 million and $9.0 million

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.